| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| TAX PREPARATION | 1,950 | 1,950 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| 5763 SHS KEYW HOLDING CORP | 2018-02 | PURCHASE | 2018-02 | 36,013 | 39,477 | -3,464 |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 1000 DUETSCHE BANK CONTINGENT | 24,250 | 25,020 |
| 1000 HSBC HOLDING | ||
| 35000 AIG 8.175 FIX ED | 41,911 | 39,900 |
| 1000 QWEST CORPORATION | 24,740 | 19,730 |
| 25000 CITIGROUP INC. SUBOR SERIES | 26,125 | 24,314 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 1000 SHS VANECK VECTORS AGRIBUSINESS | 50,285 | 56,920 |
| 1400 SHS CONAGRA FOOD INC | 29,611 | 29,904 |
| 1700 SHS DOW CHEMICAL | 80,320 | 90,916 |
| 9563 SHS BANCO SANTANDER SA ADR | 73,668 | 42,842 |
| 1869 SHS ENBRIDGE (FORMERLY SPECTRA) | 50,914 | 58,089 |
| 500 SHS CHEVRON CORP | 43,643 | 54,395 |
| 250 SHS CUMMINS INC. | 29,126 | 33,410 |
| 1100 SHS NOVARTIS ADR | 88,470 | 94,391 |
| 900 SHS SCHLUMBERGER LTD | 71,206 | 32,472 |
| 475 SHS JOHNSON & JOHNSON | 33,684 | 61,299 |
| 955 SHS JPMORGAN CHASE | 43,784 | 93,227 |
| 1085 SHS APPLE | 65,167 | 171,148 |
| 750 SHS BERKSHIRE HATHAWAY | 123,713 | 153,135 |
| 400 SHS HOME DEPOT | 73,960 | 68,728 |
| 1000 SHS ROYAL DUTCH SHELL | 51,266 | 58,270 |
| 2000 SHS ENTERPRISE PRDTS PRTN LP | 46,220 | 49,180 |
| 20 SHS WELLS FARGO 7.5% PFD | 24,174 | 25,238 |
| 1500 SHS AT&T | 52,199 | 42,810 |
| BANK OF AMERICA - 1685 SHS | 49,716 | 41,518 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| FIDELITY CONTRAFUND | AT COST | 174,103 | 158,344 |
| FIDELITY DISCOVERY | AT COST | 155,372 | 115,143 |
| FIDELITY SELECT BIOTECH | AT COST | 109,085 | 94,565 |
| OAKMARK GLOBAL SELECT | AT COST | 61,154 | 53,390 |
| PRIMECAP ODYSSEY GROWTH FUND | AT COST | 68,064 | 84,475 |
| PRIMECAP ODYSSEY AGGRESSIVE GROWTH | AT COST | 119,321 | 136,846 |
| VANGUARD HEALTH CARE INVESTOR | AT COST | 65,038 | 56,111 |
| PRIMECAP ODYSSEY STOCK FUND | AT COST | 182,892 | 164,603 |
| ROYCE SPECIAL EQUITY INVESTMENT | AT COST | 111,276 | 84,370 |
| INVESCO EUROPEAN SMALL COMPANY | AT COST | 42,715 | 34,250 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| INVESTMENT EXPENSES - ACCOUNT | 8,838 | 8,838 | 8,838 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES AND FEES | 792 | 792 | 792 | |
| FEDERAL TAXES | 1,840 | 1,840 |